Cell Signaling Technology Logo - Extra Large

CCNA2 Antibodies

You can find the right CCNA2 antibody for your scientific research with our 6 antibodies developed in Mouse and Rabbit. These antibodies are validated for detecting CCNA2 in Human, Mouse and Rat samples using techniques like Western Blotting, Immunofluorescence (Immunocytochemistry), Immunohistochemistry (Paraffin), Flow Cytometry (Fixed/Permeabilized), Immunofluorescence (Frozen), Immunoprecipitation and Simple Western™. Our CCNA2 antibodies have been cited in 440 publications and have 52 product images.

Target Information

Cyclin which controls both the G1/S and the G2/M transition phases of the cell cycle. Functions through the formation of specific serine/threonine protein kinase holoenzyme complexes with the cyclin-dependent protein kinases CDK1 or CDK2. The cyclin subunit confers the substrate specificity of these complexes and differentially interacts with and activates CDK1 and CDK2 throughout the cell cycle. Belongs to the cyclin family. Cyclin AB subfamily. Note: This description may include information from UniProtKB.

Alternate Names

CCN1; CCNA; CCNA2; Cyclin A; cyclin A2; Cyclin-A; Cyclin-A2

CCNA2 Antibody Products

6 Products
Product #
Product Name
Applications
Reactivity
Clonality

1-6 of 6
Application Key:
WB - Western
IHC - Immunohistochemistry
IF - Immunofluorescence
F - Flow Cytometry
ChIP - Chromatin Immunoprecipitation
ELISA+ - ELISA and/or ELISA-like Assays
Species Cross-Reactivity Key:
H-Human M-Mouse R-Rat Hm-Hamster Mk-Monkey Vir-Virus Mi-Mink C-Chicken Dm-D. melanogaster X-Xenopus Z-Zebrafish B-Bovine Dg-Dog Pg-Pig Sc-S. cerevisiae Ce-C. elegans Hr-Horse GP-Guinea Pig Rab-Rabbit All-All Species Expected

Why CST

Cell Signaling Technology is trusted by the global scientific research community. Our highly cited antibodies offer unrivaled specificity and reproducibility. Learn more about why researchers choose CST:

Contact

Don’t see an antibody for your specific needs? Browse more products, learn more about our services or get in touch with us: